» Articles » PMID: 32736626

The Current Landscape of Pre-exposure Prophylaxis Service Delivery Models for HIV Prevention: a Scoping Review

Overview
Publisher Biomed Central
Specialty Health Services
Date 2020 Aug 2
PMID 32736626
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Strengthening HIV prevention is imperative given the continued high HIV incidence worldwide. The introduction of oral PrEP as a new biomedical HIV prevention tool can be a potential game changer because of its high clinical efficacy and the feasibility of its provision to different key populations. Documenting the existing experience with PrEP service delivery in a variety of real-world settings will inform how its uptake and usage can be maximised.

Methods: We conducted a scoping review using the five-step framework provided by Arksey and O'Malley. We systematically searched the existing peer-reviewed international and grey literature describing the implementation of real-world PrEP service delivery models reporting on four key components: the target population of PrEP services, the setting where PrEP was delivered, PrEP providers' professionalisation and PrEP delivery channels. We restricted our search to English language articles. No geographical or time restrictions were set.

Results: This review included 33 articles for charting and analysing of the results. The identified service delivery models showed that PrEP services mainly targeted people at high risk of HIV acquisition, with some models targeting specific key populations, mainly men who have sex with men. PrEP was often delivered centralised and in a clinical or hospital setting. Yet also community-based as well as home-based PrEP delivery models were reported. Providers of PrEP were mainly clinically trained health professionals, but in some rare cases community workers and lay providers also delivered PrEP. In general, in-person visits were used to deliver PrEP. More innovative digital options using mHealth and telemedicine approaches to deliver specific parts of PrEP services are currently being applied in a minority of the service delivery models in mainly high-resource settings.

Conclusions: A range of possible combinations was found between all four components of PrEP service delivery models. This reflects differentiation of care according to different contextual settings. More research is needed on how integration of services in these contexts could be expanded and optimised to respond to key populations with unmet HIV prevention needs in different settings.

Citing Articles

Updates on HIV Pre-exposure Prophylaxis in Latin America: Available Drugs and Implementation Status.

Gonzales-Gavancho C, Araoz-Salinas J, Ramon Tapia R, Quispe-Vicuna C, Reategui-Garcia M, Rios-Garcia W Infez Med. 2025; 33(1):29-49.

PMID: 40071257 PMC: 11892447. DOI: 10.53854/liim-3301-4.


Determinants of Familiarity and Experience with HIV Pre-Exposure Prophylaxis in Primary Care Providers in Ontario, Canada.

Martinez-Cajas J, Alvarado B, Rapino C, Nagy E, Guan T, Cofie N J Prim Care Community Health. 2025; 16():21501319251315566.

PMID: 39846350 PMC: 11755537. DOI: 10.1177/21501319251315566.


Health and economic impact of oral PrEP provision across subgroups in western Kenya: a modelling analysis.

Wittenauer R, Wu L, Cox S, Pfau B, Sharma M BMJ Glob Health. 2025; 10(1.

PMID: 39800385 PMC: 11749867. DOI: 10.1136/bmjgh-2024-015835.


HIV Pre-exposure prophylaxis (PrEP) Modalities and Service Delivery Preferences Among Black Cisgender Emerging and Older Adult Women in Baltimore, Maryland.

Knight D, Saleem H, Baral S, German D, Willie T Res Sq. 2024; .

PMID: 39606438 PMC: 11601849. DOI: 10.21203/rs.3.rs-5112395/v1.


Health System Factors Influencing the Integration of Pre-Exposure Prophylaxis into Antenatal and Postnatal Clinic Services in Cape Town, South Africa.

Court L, Nelson A, Taliep R, Dean S, Mvududu R, Knight L Glob Health Sci Pract. 2024; 12(6).

PMID: 39578094 PMC: 11666089. DOI: 10.9745/GHSP-D-24-00166.


References
1.
Kurth A, Celum C, Baeten J, Vermund S, Wasserheit J . Combination HIV prevention: significance, challenges, and opportunities. Curr HIV/AIDS Rep. 2010; 8(1):62-72. PMC: 3036787. DOI: 10.1007/s11904-010-0063-3. View

2.
Fonner V, Dalglish S, Kennedy C, Baggaley R, OReilly K, Koechlin F . Effectiveness and safety of oral HIV preexposure prophylaxis for all populations. AIDS. 2016; 30(12):1973-83. PMC: 4949005. DOI: 10.1097/QAD.0000000000001145. View

3.
Hodges-Mameletzis I, Dalal S, Msimanga-Radebe B, Rodolph M, Baggaley R . Going global: the adoption of the World Health Organization's enabling recommendation on oral pre-exposure prophylaxis for HIV. Sex Health. 2018; 15(6):489-500. DOI: 10.1071/SH18125. View

4.
Nunn A, Brinkley-Rubinstein L, Oldenburg C, Mayer K, Mimiaga M, Patel R . Defining the HIV pre-exposure prophylaxis care continuum. AIDS. 2017; 31(5):731-734. PMC: 5333727. DOI: 10.1097/QAD.0000000000001385. View

5.
Nwokolo N, Hill A, Mcowan A, Pozniak A . Rapidly declining HIV infection in MSM in central London. Lancet HIV. 2017; 4(11):e482-e483. DOI: 10.1016/S2352-3018(17)30181-9. View